• OPEN AN ACCOUNT
Indian Indices
Nifty
26,068.15 -124.00
(-0.47%)
Sensex
85,231.92 -400.76
( -0.47%)
Bank Nifty
58,867.70 -480.00
( -0.81%)
Nifty IT
36,885.35 -157.95
( -0.43%)
Global Indices
Nasdaq
46,275.21 501.96
(1.10%)
Dow Jones
6,624.30 64.54
(0.98%)
Hang Seng
48,653.14 -1,170.80
(-2.35%)
Nikkei 225
9,535.95 8.30
(0.09%)
Forex
USD-INR
88.67 0.16
(0.19%)
EUR-INR
102.19 -0.14
(-0.14%)
GBP-INR
115.88 -0.12
(-0.10%)
JPY-INR
0.56 0.00
(-0.65%)

EQUITY - MARKET SCREENER

Syschem (India) Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
531173
INE121D01036
21.8003355
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
53.58
242.45
EPS(TTM)
Face Value()
Div & Yield %
1.04
10
0
 

maruti suzuki india ltd
Pfizer jumps after robust Q1 earnings
Aug 14,2025
On a standalone basis, net profit rose 27.23% year-on-year to Rs 191.75 crore in Q1 FY26 from Rs 150.71 crore in Q1 FY25, but fell 3.3% sequentially from adjusted net profit of Rs 198.33 crore in Q4 FY25.

Revenue from operations stood at Rs 603.05 crore, up 7.14% YoY from Rs 562.86 crore and 1.88% higher than Rs 591.91 crore in the March quarter.

Profit before tax and exceptional items stood at Rs 259.53 crore in Q1 FY26, up 28.09% YoY and up 2.59% from Rs 252.99 crore in Q4 FY25.

Total expenditure rose 1.99% YoY to Rs 393.03 crore from Rs 385.37 crore and was up 7.86% sequentially from Rs 364.41 crore. Cost of material consumed jumped 53.60% YoY to Rs 88.69 crore in Q1 FY26.

Pfizer is one of the world’s leading pharmaceutical companies, specialising in four key business categories — vaccines, hospitals, internal medicine, and inflammation & immunology.